Commentary: Reaching a milestone in diagnosing coeliac disease

British Medical Journal

Volumn 334, Issue 7596, 2007, Pages 732-733

  Graber, Mark L ^a   Kumar, Atul ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

CELIAC DISEASE; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; INTESTINE BIOPSY; NOTE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; DECISION SUPPORT SYSTEM; GASTROSCOPY;

CELIAC DISEASE; DECISION SUPPORT TECHNIQUES; GASTROSCOPY; HUMANS;

EID: 34247209519     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39161.587720.BE     Document Type: Note

References (4)

1. Hopper AD, Cross SS, Hurlstone DP, McAlindon ME, Lobo AJ, Hadjivassiliou M, et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007; 334: 729-32.
2. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131:1981-2002.
3. Green PHR, Stavropolous SN, Panagi SG, Goldstein SL, McMahon DJ, Absan H, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastro 2001;96:126-31.
4. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. User's guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA 2000;284:79-84.